Company Overview of T-Cyte Therapeutics, Inc.
T-Cyte Therapeutics, Inc. manufactures and distributes immune modulating proteins for cats infected with feline leukemia virus (FeLV) and/or feline immunodeficiency virus (FIV). It offers Lymphocyte T-Cell Immunomodulator, a treatment aid for cats infected with FeLV and FIV, as well as associated symptoms of lymphopenia, opportunistic infection, anemia, granulocytopenia, and thrombocytopenia. The company sells its products through licensed veterinarians in the United States. T-Cyte Therapeutics, Inc. is based in Murrieta, California.
41718 Eastman Drive
Murrieta, CA 92562
Key Executives for T-Cyte Therapeutics, Inc.
T-Cyte Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact T-Cyte Therapeutics, Inc., please visit tcyte.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.